Search

everythinglearnresearchcommunity

for

Search:↓

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Growth hormone may protect skin from radiation damage.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Nitroglycerin ointment is now used to treat several skin conditions with fewer side effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

TRH stimulates human hair growth and extends the hair growth phase.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

A new treatment for hair loss shows promise with fewer side effects.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

AH-001 could be a safer and more effective treatment for hair loss.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.